Literature DB >> 1808617

Stereoselective disposition of ibuprofen enantiomers in the isolated perfused rat kidney.

H Y Ahn1, F Jamali, S R Cox, D Kittayanond, D E Smith.   

Abstract

The renal clearance of ibuprofen enantiomer was studied separately in the isolated perfused rat kidney at initial perfusate concentrations of 10 micrograms/ml (n = 4) and 100 micrograms/ml (n = 4). Perfusate and urine samples were measured for R(-) and S(+)-ibuprofen using a stereospecific HPLC assay; urine samples were also analyzed after alkaline hydrolysis. Functional viability of the kidney was assured by determining the fractional excretion of glucose and glomerular filtration rate (GFR) at similar perfusion pressures. The clearance of ibuprofen was equivalent to the apparent formation clearance of conjugated enantiomer since unchanged ibuprofen could not be detected in the urine. At 10 and 100 micrograms/ml, the clearance (+/- SD) of R(-)-ibuprofen was 2.50 +/- 1.28 and 2.19 +/- 1.42 microliters/min, respectively. At 100 micrograms/ml, the clearance of S(+)-ibuprofen was 0.805 +/- 0.290 microliters/min. The protein binding of ibuprofen was found to be concentration dependent and favored the R(-)-enantiomer. The excretion ratio (clearance corrected for free fraction and GFR) of R(-)-ibuprofen was 0.398 +/- 0.209 and 0.295 +/- 0.209 for perfusate concentrations of 10 and 100 micrograms/ml, respectively. The excretion ratio of S(+)-ibuprofen was 0.0886 +/- 0.0335 for perfusate concentrations of 100 micrograms/ml. These results demonstrate that the sum of renal mechanisms involved for the clearance of R(-)- and S(+)-ibuprofen was net reabsorption. Ibuprofen was recovered in the urine solely as conjugated material and no evidence of R(-) to S(+) conversion was observed. In addition, the data suggest that R(-)-ibuprofen is cleared through the kidney faster than its S(+)-enantiomer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1808617     DOI: 10.1023/a:1015898401156

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

Review 1.  The isolated perfused rat kidney.

Authors:  B D Ross
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

Review 2.  Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs.

Authors:  R K Verbeeck
Journal:  J Rheumatol Suppl       Date:  1988-10

3.  Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses.

Authors:  R T Foster; F Jamali; A S Russell; S R Alballa
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

4.  Liquid-chromatographic assay of ibuprofen enantiomers in plasma.

Authors:  R Mehvar; F Jamali; F M Pasutto
Journal:  Clin Chem       Date:  1988-03       Impact factor: 8.327

5.  Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans.

Authors:  T N Tozer; J G Gambertoglio; D E Furst; D S Avery; N H Holford
Journal:  J Pharm Sci       Date:  1983-12       Impact factor: 3.534

Review 6.  Nonsteroidal anti-inflammatory drugs.

Authors:  M D Murray; D C Brater
Journal:  Clin Geriatr Med       Date:  1990-05       Impact factor: 3.076

7.  Metabolic activities of the isolated perfused rat kidney.

Authors:  J M Nishiitsutsuji-Uwo; B D Ross; H A Krebs
Journal:  Biochem J       Date:  1967-06       Impact factor: 3.857

8.  Renal transport kinetics of chlorothiazide in the isolated perfused rat kidney.

Authors:  L J Lee; J A Cook; D E Smith
Journal:  J Pharmacol Exp Ther       Date:  1988-10       Impact factor: 4.030

9.  Dose-dependent pharmacokinetics of ibuprofen in the rat.

Authors:  A Shah; D Jung
Journal:  Drug Metab Dispos       Date:  1987 Mar-Apr       Impact factor: 3.922

10.  Stereoselective disposition of ibuprofen enantiomers in man.

Authors:  E J Lee; K Williams; R Day; G Graham; D Champion
Journal:  Br J Clin Pharmacol       Date:  1985-05       Impact factor: 4.335

View more
  4 in total

Review 1.  Drug interactions at the renal level. Implications for drug development.

Authors:  P L Bonate; K Reith; S Weir
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of ketorolac tromethamine.

Authors:  D R Brocks; F Jamali
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

4.  Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.

Authors:  D R Brocks; F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Oct-Dec       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.